0.377
price down icon5.70%   -0.0228
after-market Dopo l'orario di chiusura: .38 0.003 +0.80%
loading
Precedente Chiudi:
$0.3998
Aprire:
$0.3953
Volume 24 ore:
660.17K
Relative Volume:
1.09
Capitalizzazione di mercato:
$22.02M
Reddito:
-
Utile/perdita netta:
$-123.46M
Rapporto P/E:
-0.1456
EPS:
-2.59
Flusso di cassa netto:
$-104.11M
1 W Prestazione:
+1.73%
1M Prestazione:
-4.56%
6M Prestazione:
-24.54%
1 anno Prestazione:
-77.95%
Intervallo 1D:
Value
$0.3718
$0.415
Intervallo di 1 settimana:
Value
$0.3254
$0.415
Portata 52W:
Value
$0.2601
$2.525

Bioatla Inc Stock (BCAB) Company Profile

Name
Nome
Bioatla Inc
Name
Telefono
858-558-0708
Name
Indirizzo
11085 TORREYANA ROAD, SAN DIEGO
Name
Dipendente
61
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-21
Name
Ultimi documenti SEC
Name
BCAB's Discussions on Twitter

Confronta BCAB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BCAB
Bioatla Inc
0.377 19.94M 0 -123.46M -104.11M -2.59
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Bioatla Inc Stock (BCAB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-13 Downgrade H.C. Wainwright Buy → Neutral
2022-09-15 Iniziato JMP Securities Mkt Outperform
2022-05-05 Downgrade Credit Suisse Outperform → Neutral
2022-03-21 Iniziato H.C. Wainwright Buy
2021-10-15 Ripresa BTIG Research Buy
2021-06-28 Iniziato ROTH Capital Buy
2021-05-05 Ripresa Credit Suisse Outperform
2021-04-26 Ripresa Credit Suisse Outperform
2021-01-11 Iniziato BTIG Research Buy
2021-01-11 Iniziato Credit Suisse Outperform
2021-01-11 Iniziato JP Morgan Overweight
2021-01-11 Iniziato Jefferies Buy
Mostra tutto

Bioatla Inc Borsa (BCAB) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about BioAtla Inc. stockConsistently high returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 22, 2025

What drives BioAtla Inc. stock priceFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

BioAtla Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Now The Time To Buy BioAtla Inc (NASDAQ: BCAB) Stock? - Stocksregister

Jul 22, 2025
pulisher
Jul 22, 2025

Is BioAtla Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is BioAtla Inc. stock a good hedge against inflationFree Consultation - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

What analysts say about BioAtla Inc. stock outlookFast Gains With Reduced Risk - beatles.ru

Jul 19, 2025
pulisher
Jul 17, 2025

BioAtla Announces Upcoming Oral Presentation at the 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting - The Manila Times

Jul 17, 2025
pulisher
Jul 15, 2025

What makes BioAtla Inc. stock price move sharplyTrending Stock Alert - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why BioAtla Inc. stock attracts strong analyst attentionStable Stocks With High Yield - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How BioAtla Inc. stock performs during market volatilityPortfolio Boosting Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 08, 2025

BioAtla (NASDAQ:BCAB) Stock Price Up 2.6% – Here’s Why - Defense World

Jul 08, 2025
pulisher
Jul 04, 2025

BioAtla presents Phase I data of BA3182 for metastatic adenocarcinoma - Yahoo Finance

Jul 04, 2025
pulisher
Jun 20, 2025

BioAtla Approves 2025 Corporate Bonus Plan - TipRanks

Jun 20, 2025
pulisher
Jun 14, 2025

BioAtla, Inc. (NASDAQ:BCAB) Shares Purchased by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Purchases 100,204 Shares of BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

BioAtla, Inc. (NASDAQ:BCAB) Stock Position Lowered by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Millennium Management LLC Cuts Stock Position in BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

BioAtla (NASDAQ:BCAB) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

BioAtla presents Phase 2 Oz-V clinical trial data at ASCO 2025 - MSN

Jun 06, 2025
pulisher
Jun 03, 2025

Why Did BioAtla Inc (NASDAQ: BCAB) Drop So Much? - Stocksregister

Jun 03, 2025
pulisher
Jun 03, 2025

BioAtla reports promising trial results for cancer drug By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

BioAtla reports promising trial results for cancer drug - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

BioAtla (BCAB) Showcases Promising Data for Ozuriftamab Vedotin in Key Cancer Trial | BCAB Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

BioAtla's New Cancer Drug Achieves 13x Better Response Rate Than Standard Treatment in Phase 2 Trial - Stock Titan

Jun 02, 2025
pulisher
May 28, 2025

BioAtla’s SWOT analysis: CAB platform stock faces pivotal year amid clinical trials - Investing.com Nigeria

May 28, 2025

Bioatla Inc Azioni (BCAB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):